FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W105033414> ?p ?o ?g. }

• W105033414 endingPage "2312" @default.
• W105033414 startingPage "2305" @default.
• W105033414 abstract "The purpose of the present study was to translate our laboratory investigations to establish safety and efficacy of 8 weeks of chronic SC B-type natriuretic peptide (BNP) administration in human Stage C heart failure (HF).B-Type natriuretic peptide is a cardiac hormone with vasodilating, natriuretic, renin-angiotensin inhibiting, and lusitropic properties. We have previously demonstrated that chronic cardiac hormone replacement with subcutaneous (SC) administration of BNP in experimental HF resulted in improved cardiovascular function.We performed a randomized double-blind placebo-controlled proof of concept study comparing 8 weeks of SC BNP (10 μg/kg bid) (n = 20) with placebo (n = 20) in patients with ejection fraction <35% and New York Heart Association functional class II to III HF. Primary outcomes were left ventricular (LV) volumes and LV mass determined by cardiac magnetic resonance imaging. Secondary outcomes include LV filling pressure by Doppler echo, humoral function, and renal function.Eight weeks of chronic SC BNP resulted in a greater reduction of LV systolic and diastolic volume index and LV mass index as compared with placebo. There was a significantly greater improvement of Minnesota Living with Heart Failure score, LV filling pressure as demonstrated by the reductions of E/e' ratio, and decrease in left atrial volume index as compared with placebo. Glomerular filtration rate was preserved with SC BNP, as was the ability to activate plasma 3',5'-cyclic guanosine monophosphate (p < 0.05 vs. placebo).In this pilot proof of concept study, chronic protein therapy with SC BNP improved LV remodeling, LV filling pressure, and Minnesota Living with Heart Failure score in patients with stable systolic HF on optimal therapy. Renin-angiotensin was suppressed, and glomerular filtration rate was preserved. Subcutaneous BNP represents a novel, safe, and efficacious protein therapeutic strategy in human HF. Further studies are warranted to determine whether these physiologic observations can be translated into improved clinical outcomes and ultimately delay the progression of HF. (Cardiac Hormone Replacement With BNP in Heart Failure: A Novel Therapeutic Strategy; NCT00252187)." @default.
• W105033414 created "2016-06-24" @default.
• W105033414 creator A5014193048 @default.
• W105033414 creator A5028644714 @default.
• W105033414 creator A5032149559 @default.
• W105033414 creator A5052263620 @default.
• W105033414 creator A5087303093 @default.
• W105033414 creator A5090322167 @default.
• W105033414 date "2012-12-01" @default.
• W105033414 modified "2023-10-14" @default.
• W105033414 title "Novel Protein Therapeutics for Systolic Heart Failure" @default.
• W105033414 cites W153351502 @default.
• W105033414 cites W1969677127 @default.
• W105033414 cites W1974095228 @default.
• W105033414 cites W1979026148 @default.
• W105033414 cites W1989282674 @default.
• W105033414 cites W1999413365 @default.
• W105033414 cites W2016023383 @default.
• W105033414 cites W2019764408 @default.
• W105033414 cites W2024515082 @default.
• W105033414 cites W2033989169 @default.
• W105033414 cites W2034178790 @default.
• W105033414 cites W2046665446 @default.
• W105033414 cites W2069722675 @default.
• W105033414 cites W2071575321 @default.
• W105033414 cites W2092609165 @default.
• W105033414 cites W2101343361 @default.
• W105033414 cites W2123313780 @default.
• W105033414 cites W2136718447 @default.
• W105033414 cites W2148223752 @default.
• W105033414 cites W2154705621 @default.
• W105033414 cites W2163982693 @default.
• W105033414 cites W2164705414 @default.
• W105033414 cites W2166719143 @default.
• W105033414 cites W47579473 @default.
• W105033414 cites W86846889 @default.
• W105033414 doi "https://doi.org/10.1016/j.jacc.2012.07.056" @default.
• W105033414 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3555560" @default.
• W105033414 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23122795" @default.
• W105033414 hasPublicationYear "2012" @default.
• W105033414 type Work @default.
• W105033414 sameAs 105033414 @default.
• W105033414 citedByCount "89" @default.
• W105033414 countsByYear W1050334142012 @default.
• W105033414 countsByYear W1050334142013 @default.
• W105033414 countsByYear W1050334142014 @default.
• W105033414 countsByYear W1050334142015 @default.
• W105033414 countsByYear W1050334142016 @default.
• W105033414 countsByYear W1050334142017 @default.
• W105033414 countsByYear W1050334142018 @default.
• W105033414 countsByYear W1050334142019 @default.
• W105033414 countsByYear W1050334142020 @default.
• W105033414 countsByYear W1050334142021 @default.
• W105033414 countsByYear W1050334142022 @default.
• W105033414 countsByYear W1050334142023 @default.
• W105033414 crossrefType "journal-article" @default.
• W105033414 hasAuthorship W105033414A5014193048 @default.
• W105033414 hasAuthorship W105033414A5028644714 @default.
• W105033414 hasAuthorship W105033414A5032149559 @default.
• W105033414 hasAuthorship W105033414A5052263620 @default.
• W105033414 hasAuthorship W105033414A5087303093 @default.
• W105033414 hasAuthorship W105033414A5090322167 @default.
• W105033414 hasBestOaLocation W1050334141 @default.
• W105033414 hasConcept C126322002 @default.
• W105033414 hasConcept C142724271 @default.
• W105033414 hasConcept C164705383 @default.
• W105033414 hasConcept C204787440 @default.
• W105033414 hasConcept C27081682 @default.
• W105033414 hasConcept C2775846464 @default.
• W105033414 hasConcept C2775915353 @default.
• W105033414 hasConcept C2778069365 @default.
• W105033414 hasConcept C2778198053 @default.
• W105033414 hasConcept C2780994212 @default.
• W105033414 hasConcept C519581460 @default.
• W105033414 hasConcept C71924100 @default.
• W105033414 hasConcept C78085059 @default.
• W105033414 hasConceptScore W105033414C126322002 @default.
• W105033414 hasConceptScore W105033414C142724271 @default.
• W105033414 hasConceptScore W105033414C164705383 @default.
• W105033414 hasConceptScore W105033414C204787440 @default.
• W105033414 hasConceptScore W105033414C27081682 @default.
• W105033414 hasConceptScore W105033414C2775846464 @default.
• W105033414 hasConceptScore W105033414C2775915353 @default.
• W105033414 hasConceptScore W105033414C2778069365 @default.
• W105033414 hasConceptScore W105033414C2778198053 @default.
• W105033414 hasConceptScore W105033414C2780994212 @default.
• W105033414 hasConceptScore W105033414C519581460 @default.
• W105033414 hasConceptScore W105033414C71924100 @default.
• W105033414 hasConceptScore W105033414C78085059 @default.
• W105033414 hasFunder F4320332161 @default.
• W105033414 hasIssue "22" @default.
• W105033414 hasLocation W1050334141 @default.
• W105033414 hasLocation W1050334142 @default.
• W105033414 hasLocation W1050334143 @default.
• W105033414 hasLocation W1050334144 @default.
• W105033414 hasOpenAccess W105033414 @default.
• W105033414 hasPrimaryLocation W1050334141 @default.
• W105033414 hasRelatedWork W2328354663 @default.

• next